Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Rethinking clinical study data: why we should respect analysis results as data
Joana M Barros1,2, Lukas A Widmer3, Mark Baillie4
1Analytics, Novartis Pharma AG, Basel, Switzerland. joanamarquesbarros@gmail.com.
Abstract:
The development and approval of new treatments generates large volumes of results, such as summaries of efficacy and safety. However, it is commonly overlooked that analyzing clinical study data also produces data in the form of results. For example, descriptive statistics and model predictions are data. Although integrating and putting findings into context is a cornerstone of scientific work, analysis results are often neglected as a data source. Results end up stored as "data products" such as PDF documents that are not machine readable or amenable to future analyses. We propose a solution to "calculate once, use many times" by combining analysis results standards with a common data model. This analysis results data model re-frames the target of analyses from static representations of the results (e.g., tables and figures) to a data model with applications in various contexts, including knowledge discovery. Further, we provide a working proof of concept detailing how to approach standardization and construct a schema to store and query analysis results.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Statistical Software for Data Analysis and Clinical Trials
Clinical Trials
There are four phases in a clinical trial. A phase one...
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Analysis of Population Pharmacokinetic Data
Ethics in Research

